Bydureon approval a shot across bow for Victoza
January 30 2012
The FDA's go-ahead for Bydureon gives maker Amylin a much-needed win in the GLP-1 market.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.